Effector Therape -CW27EFTRWPreferred / convertible
13F holders, Q3 2024 (September 30)1holders −11
1new positions
13sold out
$0.00avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Effector Therape -CW27 (EFTRW) in their 13F filings, down 11 from Q2 2024. 1 opened new positions and 13 sold out. The largest holder was Clear Street LLC ($0).
- Company
- Effector Therape -CW27
- CUSIP
- 28202V116
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 13 | $3K |
All 13F filers, Q2 2024 → Q3 2024: 100 shares bought and 2,794,846 shares sold, net −2,794,746 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Clear Street LLC | — | New | 100 | $0 |
"% of holder's portfolio" is EFTRW's weight in each manager's 13F, not the share of Effector Therape -CW27 the manager owns.